Pharma Journalist -

CytoDyn In. announced the treatment of the first patient suffering from GvHD(Graft versus Host Disease) with use of PRO 140 during its clinical trial Phase 2. The multicenter,…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that USFDA has approved to launch Doxorubicin Hydrochloride Liposome Injection for intravenous use, in the US market. The approval is an outcome…
Read More...

Dr. Donna Morgan Murray has been appointed as Nativis Chief Regulatory Officer with immediate effective. Murray is author of more than 60 publications in peer-referenced…
Read More...

Saneca Pharma announced that after an inspection Russian Federal State Institution ‘State Institute of Drugs and Good Practices’ has granted them multi-dosage cGMP certificate. cGMP…
Read More...

MilliporeSigma announced that SystImmune has selected its CHOZN Expression System for commercial development of a bi-specific antibody therapeutic. The CHOZN expression system is…
Read More...

AVEO Oncology has appointed Matthew Dallas as CFO (chief financial officer) effective from June 1, 2017. Mr. Dallas will be responsible for the Company’s financial strategy and…
Read More...

Cambrex Corporation will invest $2.4M is to expand pilot plant capacity by around 30% at its High Point, NC facility with the installation of a fourth reactor suite. The new 400 sq.…
Read More...

Halo Pharma announces the formation of its Pediatric Center of Excellence in support of the development and manufacture of dosage forms tailored for pediatric indications. Halo Pharma…
Read More...

Bristol-Myers Squibb (BMS) and Calithera Biosciences expanded their collaboration to evaluate BMS’s Opdivo in combination with Calithera’s CB-839 in patients with non-small cell lung…
Read More...

NOXXON Pharma signed an agreement with the National Center for Tumor Diseases (NCT) in Heidelberg. Under the agreement NCT will conduct a trial evaluating NOXXON’s lead product…
Read More...